Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Commentary · 26 Jan 2023 Conference abstract · 2020 Impact of hybrid imaging with Prostate-specific membrane antigen to target prostate cancer therapy
Case report · 14 Nov 2015 Prostate-Specific Membrane Antigen-Radioguided Salvage Hemiablation High Intensity Focused Ultrasound for Radio-Recurrent Prostate Cancer
Prostate-specific membrane antigen (PSMA) is a membrane glycoprotein that is a well-characterized and clinically validated marker of prostate cancer (PCa) Gallium 68 (68Ga)–labeled PSMA PET/CT uses
Short communication · 31 Jul 2024 Advances in Prostate Cancer Surgery Accurate Identification, Real-Time Diagnosis, and Precise Resection with PSMA Targeting
accuracy of tumor identification, realtime diagnosis, and resection precision through the use of prostate-specific membrane antigen (PSMA) targeting. This paper explores the latest developments in PSMA-targeted surgical…
Conference abstract · 15 Apr 2019 Using multiplex in situ hybridization and machine learning to evaluate bi-specific binder targets in metastatic Castration Resistant Prostate Cancer (mCRPC)
tumor targeting pairs. We developed a platform that allows binder pairs for a prostate-specific membrane antigen target to be evaluated for co-localization in tumor cells using fully automated
Short communication · 2018 Clinical Approaches in Prostate Cancer Therapies
Prostate-Specific Antigen) blood test has been used in various stages of prostate cancer management, including screening and the assessment of future risk of prostate cancer development, detection ... recurrent disease…
Commentary · 30 Jun 2025 Theranostics: Bridging Diagnosis and Therapy
radio-ligand therapy in prostate cancer, where molecules targeting prostate-specific membrane antigen (PSMA) are tagged with diagnostic isotopes for imaging and with therapeutic isotopes for targeted radiotherapy. This…
Article · 2024 Contribution of 18F-PSMA PET/CT to the Extension Workup of Intermediate-Risk Prostatic ADK: A Case Report
original author and source are credited. Clinical-Medical Image PSMA PET/CT (Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography) has emerged as a significant tool in both
Research article · 2020 PSMA-Specific Peptide with Inhibitor Cystine Knot for Prostate Cancer Treatment
based on U5-scytotoxin-Sth1a toxin with an inserted peptide tropic to the prostate-specific membrane antigen and the radiopharmaceutical 177Lu-PSMA-617 is carried out. Objective and Methods
Case report · 2017 Superscan Imaging on Ga-68 PSMA PET/CT in Prostate Cancer Patient
superscan on Tc-99m bone scintigraphy is described in multiple skeletal metastatic disease. Prostate-specific membrane antigen (PSMA) is a cell surface protein with high expression in prostate carcinoma cells
Commentary · 11 Aug 2016 PSMA PET/CT imaging and therapy
Prostate-specific membrane antigen (PSMA) is increasingly recognized as a novel target for the PET imaging of prostate cancer (PCa) and 68Ga-DKFZ-11 (68Ga-PSMA) has been suggested
Conference abstract · 20 Nov 2013 Annotating oncogenic pathway signaling with zirconium-based radiotracers for PET imaging
numerous protein biomarkers like epidermal growth-factor receptor (EGFR), Her2/ neu and prostate-specific membrane antigen (PSMA) have been validated as imaging/therapeutic targets for various cancers. Yet in spite
Conference abstract · 3 Sep 2018 Assessment of Ga-68 prostate specific membrane antigen progress using PET/CT in patients with prostate cancer
serum Prostate-Specific Antigen (PSA) level. These days, new radiotracers using Positron Emission Tomography (PET) have demonstrated new insights recurrence of disease. Meanwhile, emerging Ga-68 Prostate Specific…
Research article · 2011 CD10 and Endothelin-1 are Inversely Expressed in Early Prostate Cancer and Predict Psa Failure after Radical Prostatectomy
Background: Loss of the membrane endopeptidase CD10 plays an important role in the development of neuropeptide-mediated androgen-independent prostate cancer cell growth. The aim of this study ... neuropeptide axis with…
Research article · 2011 Alcohol Drinking, Non-alcoholic Beverages and Risk of Advanced Prostate Cancer among Uruguayan Men
Background: Loss of the membrane endopeptidase CD10 plays an important role in the development of neuropeptide-mediated androgen-independent prostate cancer cell growth. The aim of this study ... value of the…
Conference abstract · 15 Oct 2012 Detection and characterization of viable circulating tumor cells in solid tumors using the EPISPOT assay
based on the expression of EpCAM. Cells are cultured for 24 hours on a membrane coated with antibodies that capture the secreted/released/shed proteins which are subsequently detected ... however, HER2-releasing CTC…
Conference abstract · 16 Mar 2015 Detection and characterization of viable circulating tumor cells as liquid biopsy for cancer
from single epithelial cancer cells. Cells are cultured for a short time on a membrane coated with antibodies that capture the secreted/released/shed proteins that are subsequently detected ... that patients with…

